Published in J Infect Dis on January 08, 2004
Validation of microsatellite markers for use in genotyping polyclonal Plasmodium falciparum infections. Am J Trop Med Hyg (2006) 2.43
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proc Natl Acad Sci U S A (2011) 2.25
Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2). Malar J (2009) 2.22
Competitive release and facilitation of drug-resistant parasites after therapeutic chemotherapy in a rodent malaria model. Proc Natl Acad Sci U S A (2007) 2.14
Estimating true antimalarial efficacy by heteroduplex tracking assay in patients with complex Plasmodium falciparum infections. Antimicrob Agents Chemother (2006) 1.76
Comparison of Plasmodium falciparum allelic frequency distribution in different endemic settings by high-resolution genotyping. Malar J (2009) 1.67
Chemotherapy, within-host ecology and the fitness of drug-resistant malaria parasites. Evolution (2010) 1.27
Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania. Antimicrob Agents Chemother (2010) 1.27
Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, Tanzania. Emerg Infect Dis (2013) 1.26
The perils of PCR: can we accurately 'correct' antimalarial trials? Trends Parasitol (2010) 1.24
Extensive dynamics of Plasmodium falciparum densities, stages and genotyping profiles. Malar J (2008) 1.24
Evolutionary biology and the avoidance of antimicrobial resistance. Evol Appl (2009) 1.16
Antimalarial drug sensitivity profile of western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay and molecular analysis. Am J Trop Med Hyg (2011) 1.10
Misclassification of drug failure in Plasmodium falciparum clinical trials in southeast Asia. J Infect Dis (2009) 1.05
Demonstration of a high level of parasite population homology by quantification of Plasmodium falciparum alleles in matched peripheral, placental, and umbilical cord blood samples. J Clin Microbiol (2005) 1.05
Plasmodium falciparum population dynamics during the early phase of anti-malarial drug treatment in Tanzanian children with acute uncomplicated malaria. Malar J (2011) 1.02
Enhanced transmission of drug-resistant parasites to mosquitoes following drug treatment in rodent malaria. PLoS One (2012) 1.01
The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection. J Evol Biol (2011) 0.93
Plasmodium falciparum malaria and atovaquone-proguanil treatment failure. Emerg Infect Dis (2008) 0.93
Ahead of the curve: next generation estimators of drug resistance in malaria infections. Trends Parasitol (2013) 0.92
CD4+T cells do not mediate within-host competition between genetically diverse malaria parasites. Proc Biol Sci (2008) 0.92
Plasmodium falciparum population dynamics in a cohort of pregnant women in Senegal. Malar J (2010) 0.89
Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa. Malar J (2006) 0.86
Use of a locked-nucleic-acid oligomer in the clamped-probe assay for detection of a minority Pfcrt K76T mutant population of Plasmodium falciparum. J Clin Microbiol (2005) 0.86
Cytoadherence and genotype of Plasmodium falciparum strains from symptomatic children in Franceville, southeastern Gabon. Clin Med Res (2007) 0.78
Competition between Plasmodium falciparum strains in clinical infections during in vitro culture adaptation. Infect Genet Evol (2014) 0.77
Surveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countries. PLoS One (2013) 0.77
Attenuation of Plasmodium falciparum in vitro drug resistance phenotype following culture adaptation compared to fresh clinical isolates in Cambodia. Malar J (2015) 0.76
A deep sequencing tool for partitioning clearance rates following antimalarial treatment in polyclonal infections. Evol Med Public Health (2016) 0.76
The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults. Am J Respir Crit Care Med (2002) 2.79
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar J (2009) 2.33
Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration. Antimicrob Agents Chemother (2006) 1.89
Predictive factors of malaria in travelers to areas where malaria is endemic. Arch Intern Med (2002) 1.86
Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS One (2010) 1.86
Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression. Comput Methods Programs Biomed (2010) 1.85
Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007. Antimicrob Agents Chemother (2010) 1.76
Evaluation of the intra- and inter-specific genetic variability of Plasmodium lactate dehydrogenase. Malar J (2007) 1.71
Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility. Antimicrob Agents Chemother (2009) 1.70
The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis? Malar J (2007) 1.69
The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fundam Clin Pharmacol (2003) 1.58
Twelve months of routine HIV screening in 6 emergency departments in the Paris area: results from the ANRS URDEP study. PLoS One (2012) 1.56
Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations. Microbes Infect (2006) 1.56
Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J (2006) 1.51
Chimpanzee malaria parasites related to Plasmodium ovale in Africa. PLoS One (2009) 1.49
Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine. Trop Med Int Health (2005) 1.48
Hospitalization criteria in imported falciparum malaria. J Travel Med (2007) 1.45
Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One (2007) 1.44
Absence of efficacy of nonviable Lactobacillus acidophilus for the prevention of traveler's diarrhea: a randomized, double-blind, controlled study. Clin Infect Dis (2006) 1.42
Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir. AIDS (2006) 1.42
World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility. Malar J (2007) 1.41
[Rapid detection of malaria and P. falciparum chemoresistant genotypes in Mayotte, 2001]. Presse Med (2002) 1.41
Resistance to dihydroartemisinin. Emerg Infect Dis (2006) 1.40
Do African immigrants living in France have long-term malarial immunity? Am J Trop Med Hyg (2005) 1.39
Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996-2003. Emerg Infect Dis (2007) 1.37
Combined deletions of pfhrp2 and pfhrp3 genes result in Plasmodium falciparum malaria false-negative rapid diagnostic test. J Clin Microbiol (2011) 1.34
PfHRP2 and PfLDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria. Malar J (2009) 1.29
Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children. Antimicrob Agents Chemother (2003) 1.24
Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers. J Antimicrob Chemother (2005) 1.23
Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa. Am J Trop Med Hyg (2010) 1.18
Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone. Trop Med Int Health (2006) 1.18
DHFR and DHPS genotypes of Plasmodium falciparum isolates from Gabon correlate with in vitro activity of pyrimethamine and cycloguanil, but not with sulfadoxine-pyrimethamine treatment efficacy. J Antimicrob Chemother (2003) 1.16
High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool. Antimicrob Agents Chemother (2013) 1.15
Severe imported Plasmodium falciparum malaria, France, 1996-2003. Emerg Infect Dis (2011) 1.15
Herpes esophagitis: a comprehensive review. Clin Microbiol Infect (1997) 1.13
Parallel evolution of adaptive mutations in Plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment. Mol Biol Evol (2007) 1.13
No evidence of Bartonella quintana but detection of Acinetobacter baumannii in head lice from elementary schoolchildren in Paris. Comp Immunol Microbiol Infect Dis (2011) 1.13
Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use. Trop Med Int Health (2005) 1.12
Prolonged Plasmodium falciparum infection in immigrants, Paris. Emerg Infect Dis (2008) 1.10
Baseline in vitro efficacy of ACT component drugs on Plasmodium falciparum clinical isolates from Mali. Int J Parasitol (2008) 1.09
Chloroquine clinical failures in P. falciparum malaria are associated with mutant Pfmdr-1, not Pfcrt in Madagascar. PLoS One (2010) 1.09
Leishmania resistance to miltefosine associated with genetic marker. Emerg Infect Dis (2012) 1.07
PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria. Malar J (2013) 1.05
Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study. BMC Nephrol (2011) 1.03
Chloroquine-resistant malaria in travelers returning from Haiti after 2010 earthquake. Emerg Infect Dis (2012) 1.01
Adaptive differentiation of Plasmodium falciparum populations inferred from single-nucleotide polymorphisms (SNPs) conferring drug resistance and from neutral SNPs. J Infect Dis (2010) 1.00
Efficacy of sulfadoxine/pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria in Republic of Congo. Am J Trop Med Hyg (2004) 1.00
Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl. AIDS (2009) 0.99
Low autochtonous urban malaria in Antananarivo (Madagascar). Malar J (2006) 0.98
Sulphadoxine/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide national policy. Malar J (2008) 0.96
Post-malaria neurological syndrome--two cases in patients of African origin. Am J Trop Med Hyg (2008) 0.94
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011. Malar J (2013) 0.93
Rapid detection of point mutations in Plasmodium falciparum genes associated with antimalarial drugs resistance by using High-Resolution Melting analysis. J Microbiol Methods (2009) 0.93
Plasmodium falciparum malaria and atovaquone-proguanil treatment failure. Emerg Infect Dis (2008) 0.93
Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort. Antivir Ther (2012) 0.92
History and current status of Plasmodium falciparum antimalarial drug resistance in Madagascar. Scand J Infect Dis (2010) 0.92
Plasmodium falciparum Polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin. Antimicrob Agents Chemother (2013) 0.91
Near-fatal multiple organ dysfunction syndrome induced by Plasmodium malariae. Emerg Infect Dis (2009) 0.91
Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort. Antivir Ther (2012) 0.89
Imported amoebic liver abscess in France. PLoS Negl Trop Dis (2013) 0.88
Short report: lack of prediction of amodiaquine efficacy in treating Plasmodium falciparum malaria by in vitro tests. Am J Trop Med Hyg (2004) 0.88
Performance of rapid diagnostic tests for imported malaria in clinical practice: results of a national multicenter study. PLoS One (2013) 0.88
Reduced impact of pyrimethamine drug pressure on Plasmodium malariae dihydrofolate reductase gene. Antimicrob Agents Chemother (2011) 0.87
Prolonged remission of HIV-associated multicentric Castelman's disease with an anti-CD20 monoclonal antibody as primary therapy. AIDS (2003) 0.87
In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum. Malar J (2011) 0.86
Lack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from Africa. Malar J (2006) 0.86
Strongyloidiasis in man 75 years after initial exposure. Emerg Infect Dis (2011) 0.85
Analysis of circulating populations of Plasmodium falciparum in mild and severe malaria in two different epidemiological patterns in Madagascar. Trop Med Int Health (2008) 0.85
Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial. J Antimicrob Chemother (2008) 0.85
Permethrin and malathion resistance in head lice: results of ex vivo and molecular assays. J Am Acad Dermatol (2012) 0.85
Tuberculous cerebral vasculitis: retrospective study of 10 cases. Eur J Intern Med (2011) 0.85
Evaluation of the Clearview® Malaria pLDH Malaria Rapid Diagnostic Test in a non-endemic setting. Malar J (2011) 0.84
[Drug susceptibility of Plasmodium falciparum from polyclonal isolates]. J Soc Biol (2004) 0.83
Efficacy of antimalarial chemoprophylaxis among French residents travelling to Africa. Trans R Soc Trop Med Hyg (2005) 0.82
Visiting one's native country: the risks of nonadherence in HIV-infected sub-Saharan migrants--ANRS VIHVO study. J Int Assoc Provid AIDS Care (2013) 0.81
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study. PLoS One (2013) 0.81